1. Home
  2. ZLAB vs SPTN Comparison

ZLAB vs SPTN Comparison

Compare ZLAB & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SPTN
  • Stock Information
  • Founded
  • ZLAB 2013
  • SPTN 1917
  • Country
  • ZLAB China
  • SPTN United States
  • Employees
  • ZLAB N/A
  • SPTN N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • ZLAB Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SPTN 596.4M
  • IPO Year
  • ZLAB 2017
  • SPTN N/A
  • Fundamental
  • Price
  • ZLAB $35.00
  • SPTN $26.51
  • Analyst Decision
  • ZLAB Buy
  • SPTN Hold
  • Analyst Count
  • ZLAB 5
  • SPTN 1
  • Target Price
  • ZLAB $54.28
  • SPTN $26.90
  • AVG Volume (30 Days)
  • ZLAB 1.0M
  • SPTN 1.2M
  • Earning Date
  • ZLAB 08-05-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • ZLAB N/A
  • SPTN 3.28%
  • EPS Growth
  • ZLAB N/A
  • SPTN N/A
  • EPS
  • ZLAB N/A
  • SPTN N/A
  • Revenue
  • ZLAB $418,326,000.00
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • ZLAB $44.07
  • SPTN $6.00
  • Revenue Next Year
  • ZLAB $49.13
  • SPTN N/A
  • P/E Ratio
  • ZLAB N/A
  • SPTN N/A
  • Revenue Growth
  • ZLAB 43.72
  • SPTN 0.26
  • 52 Week Low
  • ZLAB $16.01
  • SPTN $17.30
  • 52 Week High
  • ZLAB $44.34
  • SPTN $26.65
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 51.28
  • SPTN 78.00
  • Support Level
  • ZLAB $34.44
  • SPTN $17.55
  • Resistance Level
  • ZLAB $38.18
  • SPTN $26.53
  • Average True Range (ATR)
  • ZLAB 1.33
  • SPTN 0.41
  • MACD
  • ZLAB -0.44
  • SPTN 1.01
  • Stochastic Oscillator
  • ZLAB 17.66
  • SPTN 98.46

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: